A systematic review and critical evaluation of the immunology of chronic fatigue syndrome
Introduction
Chronic fatigue syndrome (CFS) is characterized by disabling physical and mental fatigue, lasting at least 6 months, without an apparent physical cause [1]. The aetiology of CFS is unclear, but many have suggested a role for infection, and for changes in the immune system. Papers reporting immunological changes in CFS are numerous. However, taken as a whole, the body of literature is inconsistent and, in places, contradictory. Few firm conclusions have been drawn.
What are the reasons for this? Strober has suggested several: using groups of patients with differing primary symptoms and differing duration of illness, failing to control for potential confounding factors and using different laboratory procedures when analysing samples [2].
Several reviews of the immunology of CFS have been published. Buchwald and Komaroff [3] found “evidence of diffuse immunological dysfunction… it has not been shown that immunologic findings explain… the symptomatology of CFS.” Similarly, Wessely et al. [4] concludes that “there is evidence of some abnormality of immune function, but such changes are inconsistent, nonspecific and rarely correlate with the clinical condition” and Lloyd and Klimas [5] that “no clear conclusions can be drawn from the data.” Most recently, Patarca-Montero et al. [6] have written that “CFS is associated with immune abnormalities that can potentially account for physio- and psychopathological symptomatology” and also that “assessment of immune status reveals a heterogeneity among CFS patients.”
No systematic review has been completed. The importance of systematic reviews—which can be loosely defined as reviews in which there is a methods section—is established beyond doubt if unbiased conclusions are to be reached [7], [8]. Our group has already shown that nonsystematic general reviews in the field of CFS are associated with bias, influenced by professional affiliations and country of origin of the authors [9]. The aim of this paper is a systematic review of the immunology of CFS.
Section snippets
Method
EMBASE, MEDLINE and PSYCHINFO databases were searched from 1966 to 2000 using the strategy presented in Fig. 1. Additional checks were made with key investigators and using a personal database of 3000 CFS references maintained by one of the authors in which immunological measures are coded after visual inspection (in contrast to MESH terms). Contact was made with leading researchers in the field to check for missing/unpublished studies.
Certain a priori criteria were set for inclusion in the
Results
Over 390 studies were located in the original broad literature search. However, when located many of these were only peripherally concerned with CFS, and many others had a sample size of less than 10. Fifty-eight articles met the inclusion criteria. Although one study was principally concerned with Gulf War veterans, subjects were also stated to meet criteria for CFS and hence this was included [22].
Before rating the studies, it was decided to analyse the results in three groups: those studies
Discussion
By using a variety of sources, this literature review has sought to be comprehensive. The inclusion criteria served to limit the review to papers considering subjects with CFS conforming to standard operational definitions. Analysing studies in four groups had certain disadvantages notably that papers using different methodological approaches, and with different strengths and weaknesses, were considered as having a similar importance. However, the sheer number of papers limited the ability to
References (73)
Possible immunological effects of psychotropic medication
Psychosomatics
(1993)- et al.
Cytokine production in major depressed patients before and after clomipramine treatment
Biol Psychiatry
(1994) - et al.
Immunologic parameters in chronic fatigue syndrome, major depression, and multiple sclerosis
Am J Med
(1998) - et al.
Is depression associated with immune activation?
J Affect Disord
(1999) - et al.
A double-blind, placebo-controlled trial of intravenous immunoglobulin therapy in patients with chronic fatigue syndrome
Am J Med
(1990) - et al.
Clinical improvement in chronic fatigue syndrome is not associated with lymphocyte subsets of function or activation
Clin Immunol Immunopathol
(1997) - et al.
A study of the immunology of the chronic fatigue syndrome: correlation of immunologic parameters to health dysfunction
Clin Immunol Immunopathol
(1998) - et al.
Altered cytokine release in peripheral blood mononuclear cell cultures from patients with the chronic fatigue syndrome
Cytokine
(1991) - et al.
Chronic fatigue syndrome: clinical condition associated with immune activation
Lancet
(1991) - et al.
A controlled trial of intravenous immunoglobulin G in chronic fatigue syndrome
Am J Med
(1990)
A case-control study to assess possible triggers and cofactors in chronic fatigue syndrome
Am J Med
Chronic fatigue syndrome: identification of distinct subgroups on the basis of allergy and psychologic variables
J Allergy Clin Immunol
IgG subclass deficiencies in chronic fatigue syndrome
Lancet
In vitro effects of echinacea and ginseng on natural killer and antibody-dependent cell cytotoxicity in healthy subjects and chronic fatigue syndrome or acquired immunodeficiency syndrome patients
Immunopharmacology
The chronic fatigue syndrome: a comprehensive approach to its definition and study
Ann Intern Med
Immunological function in chronic fatigue syndrome
A review of the laboratory findings in patients with chronic fatigue syndrome
Rev Infect Dis
Immunologic studies of CFS
Clin Infect Dis
Immunology of chronic fatigue syndrome
J Chronic Fatigue Syndr
The Science of reviewing research
Ann NY Acad Sci
The medical review article: state of the art
Ann Intern Med
Reviewing the reviews: the example of chronic fatigue syndrome
JAMA
Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine
Ann NY Acad Sci
Depression and immunity: a meta-analytic review
Psychol Bull
Chronobiology in haematology and immunology
Am J Anat
Sympathetic and immune interactions during dynamic exercise. Mediation via a beta 2-adrenergic-dependent mechanism
Circulation
Immune responses associated with chronic fatigue syndrome: a case-control study
J Infect Dis
Aberrant in vitro HLA-DR expression in patients with chronic fatigue
S Afr Med J
Cell-mediated immunity in patients with chronic fatigue syndrome, healthy control subjects and patients with major depression
Clin Exp Immunol
Lymphocyte phenotype and function in the chronic fatigue syndrome
J Clin Immunol
Changes in immune parameters seen in Gulf War veterans but not in civilians with chronic fatigue syndrome
Clin Diagn Lab Immunol
Immunological abnormalities in the chronic fatigue syndrome
Med J Aust
Immunological and psychological dysfunction in patients receiving immunotherapy for chronic fatigue syndrome
Aust NZ J Psychiatry
Immunological abnormalities in CFS
J Clin Microbiol
Cited by (111)
MCP-1 is increased in patients with CFS and FM, whilst several other immune markers are significantly lower than healthy controls
2020, Brain, Behavior, and Immunity - HealthInflammatory proteins are altered in chronic fatigue syndrome—A systematic review and meta-analysis
2019, Neuroscience and Biobehavioral ReviewsPatients with Fibromyalgia and Chronic Fatigue Syndrome show increased hsCRP compared to healthy controls
2019, Brain, Behavior, and ImmunityPersistent fatigue induced by interferon-alpha: a novel, inflammation-based, proxy model of chronic fatigue syndrome
2019, PsychoneuroendocrinologyCitation Excerpt :Moreover, a recent study has found that 17 cytokines in the serum, mainly pro-inflammatory, correlate with Myalgic Encephalomyelitis (ME)/CFS severity (Montoya et al., 2017). However, a meta-analysis of findings published up to 2003 found no consistent evidence for immune dysfunction (Lyall et al., 2003); and a more recent meta-analysis found that, of the 77 markers measured, only transforming growth-factor beta (TGF-β) was consistently raised (Blundell et al., 2015), a finding also confirmed by the aforementioned study by Montoya et al. (2017). To investigate the role of the immune system further, post-infective fatigue syndrome has been used as a model for CFS.
Human herpesvirus 6 and 7 are biomarkers for fatigue, which distinguish between physiological fatigue and pathological fatigue
2016, Biochemical and Biophysical Research Communications